共 19 条
[11]
Neuroglia-mediated immunoinflammtory respones in Alzheimer ’ s disease: complement activity and therapetic approaches. Chen S,Frederickson RCA,Brunden KR. Neurobiology of Aging . 1996
[12]
Location and cell association of C1q in Alzheimer’ s disease brain. Afagh A,Cummings BJ,Cribbs DH,et al. Experimental Neurology . 1996
[13]
Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activity: implication for Alzheimer ’ s disease pathogenesis. Velazquez P,Cribbs DH,Poulos TL. Nature Medicine . 1997
[14]
RAGE and amyloid-βpeptides neurotoxicity in Alzheimer ’ s disease. Yan SD,Chen X,Fu J,et al. Nature . 1996
[15]
Hageman factor and its binding sites are present in senile plaques of Alzheimer’s disease. Yasuhara O,Walker DG,McGeer PL. Brain Research . 1994
[16]
Microglia cerebrospinal fluid antibody: significance for Alzheimer’s disease. MacRae A,Merill JE,Graves MC. Molecular and Chemical Neuropathology . 1996
[17]
Detection of interleukin-6 and 2-macroglubulin immunoreactivity in cortex and hippocampus of Alzheimer’s disease patients. Strauss S,Bauer J,Gauter U,et al. Laboratory Investigation . 1992
[18]
Distribution of clusterin in Alzheimer brain tissue. McGeer PL,Kwamata T,Walker DG. Brain Research . 1992
[19]
Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement 3 component by culture microglia cells. Haga S,Kushima Y,Miyamoto M,et al. Brain Research . 1993